NCT07253103
- Conditions
- Behavior, Blood Protein Disorders, Cancer, +17 more
- Locations
-
Not specified
Clinical trial condition
Paraproteinemias
Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.
3,004 public trials
571 recruiting studies
Paraproteinemias trial results
Not Yet Recruiting
Study Evaluating the Efficacy and Tolerance of a Zanubrutinib and BGB-11417 Combination in Patients Previously Treated for Waldenström Macroglobulinemia
NCT06547866
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- AMIENS - CH Amiens Picardie Site Sud Amiens, France
- Angers Chu Angers, France
- ANNECY - CH Annecy Genevois Annecy, France
- ARGENTEUIL - Centre hospitalier Victor Dupouy Argenteuil, France
Not Yet Recruiting
A Clinical Study on Minimal Residual Disease in Patients With Systemic Light Chain Amyloidosis
NCT07215494
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +11 more
- Locations
-
- Peking University First Hospital Beijing, Beijing Municipality, China
Not Yet Recruiting
Immune Adverse Events Registry in Onco-Hematologic Patients Treated With Immunotherapy
NCT07198958
- Conditions
- Blood Protein Disorders, Breast Diseases, Breast Neoplasms, +32 more
- Locations
-
Not specified
Not Yet Recruiting
A Single-arm Single-center Trial of Bridging GPRC5D/CD3 Bispecific Antibody Treatment With BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma
NCT07185477
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
Not specified
Not Yet Recruiting
Study of CM336 in Relapsed or Refractory Multiple Myeloma Patients
NCT07181239
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China
Not Yet Recruiting
A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies
NCT07107204
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +23 more
- Locations
-
Not specified
Not Yet Recruiting
Risk-adapted Therapeutic Strategy in +1q NDMM
NCT07045168
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- The First Hospital of Jilin University Changchun, Jilin, China
Not Yet Recruiting
Ibrutinib Followed by BR (Bendamustine and Rituximab) as a Time-Limited Therapy for Waldenström Macroglobulinemia
NCT07169565
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
Not specified
Not Yet Recruiting
RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies
NCT07113496
- Conditions
- B-cell Acute Lymphoblastic Leukemia (B-ALL), Blood Protein Disorders, Burkitt Lymphoma, +34 more
- Locations
-
- The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China